Summary

OUR BACKERS Supported by top investors and US research agencies Partners Partnered with over 25 companies, from small biotechs to big pharma Contact us read about asimov In the press News Blog announcement science technology Lonza and Asimov Collaborate to Advance In Vivo Lentiviral Vector Manufacturing Lonza and Asimov Collaborate to Advance In Vivo Lentiviral Vector Manufacturing Lonza and Asimov Collaborate to Advance In Vivo Lentiviral Vector Manufacturing October 2, 2026 October 2, 2026 Read more Read more Blog announcement science technology Minaris and Asimov Partner to Advance AAV Manufacturing with OXGENE Technology Minaris and Asimov Partner to Advance AAV Manufacturing with OXGENE Technology Minaris and Asimov Partner to Advance AAV Manufacturing with OXGENE Technology September 24, 2026 September 24, 2026 Read more Read more Blog announcement science technology Asimov Announces Cell Line Development Partnership with Sidewinder Therapeutics to Advance 4-Chain Bispecific Antibody for Solid Tumors Asimov Announces Cell Line Development Partnership with Sidewinder Therapeutics to Advance 4-Chain Bispecific Antibody for Solid Tumors Asimov Announces Cell Line Development Partnership with Sidewinder Therapeutics to Advance 4-Chain Bispecific Antibody for Solid Tumors September 14, 2026 September 14, 2026 Read more Read more Blog announcement science technology Asimov Announces Cell Line Development Partnership with Kaigene to Advance Multispecific Antibody for Autoimmune Disease Asimov Announces Cell Line Development Partnership with Kaigene to Advance Multispecific Antibody for Autoimmune Disease Asimov Announces Cell Line Development Partnership with Kaigene to Advance Multispecific Antibody for Autoimmune Disease August 18, 2026 August 18, 2026 Read more Read more Blog announcement science technology Kyungdong Pharmaceutical and Asimov Announce Completion of Cell Line Development Campaign for Biosimilar Antibody Kyungdong Pharmaceutical and Asimov Announce Completion of Cell Line Development Campaign for Biosimilar Antibody Kyungdong Pharmaceutical and Asimov Announce Completion of Cell Line Development Campaign for Biosimilar Antibody August 9, 2026 August 9, 2026 Read more Read more Blog announcement science technology Asimov Joins the Genesis Mission, Using Boston Universitys NSF-Backed Cloud Lab to Power Lab-in-the-Loop AI Models Asimov Joins the Genesis Mission, Using Boston Universitys NSF-Backed Cloud Lab to Power Lab-in-the-Loop AI Models Asimov Joins the Genesis Mission, Using Boston Universitys NSF-Backed Cloud Lab to Power Lab-in-the-Loop AI Models July 24, 2026 July 24, 2026 Read more Read more Blog announcement science technology Asimov Launches Chrysalis Transposase, a Wholly-Owned Genome Integration Tool for Biotherapeutics Production Asimov Launches Chrysalis Transposase, a Wholly-Owned Genome Integration Tool for Biotherapeutics Production Asimov Launches Chrysalis Transposase, a Wholly-Owned Genome Integration Tool for Biotherapeutics Production June 23, 2026 June 23, 2026 Read more Read more Blog announcement science technology Asimov Announces Strategic Partnership with the Rosalind Morris Goodman Cancer Institute at McGill University to Advance Next-Generation Biologics Asimov Announces Strategic Partnership with the Rosalind Morris Goodman Cancer Institute at McGill University to Advance Next-Generation Biologics Asimov Announces Strategic Partnership with the Rosalind Morris Goodman Cancer Institute at McGill University to Advance Next-Generation Biologics June 18, 2026 June 18, 2026 Read more Read more Blog announcement science technology Asimov Completes Lead Optimization Campaign with Mabylon AG to Advance Trispecific Antibody for Tree Pollen Allergies Asimov Completes Lead Optimization Campaign with Mabylon AG to Advance Trispecific Antibody for Tree Pollen Allergies Asimov Completes Lead Optimization Campaign with Mabylon AG to Advance Trispecific Antibody for Tree Pollen Allergies May 7, 2026 May 7, 2026 Read more Read more Blog announcement science technology Asimov Launches RNA Edge, a Lab-in-the-Loop Platform for AI Optimization of RNA Therapeutic Candidates Asimov Launches RNA Edge, a Lab-in-the-Loop Platform for AI Optimization of RNA Therapeutic Candidates Asimov Launches RNA Edge, a Lab-in-the-Loop Platform for AI Optimization of RNA Therapeutic Candidates March 19, 2026 March 19, 2026 Read more Read more Blog announcement science technology Asimov Announces Cell Line Development Partnership with Score Pharma to Advance Biosuperior Antibody Therapeutics Asimov Announces Cell Line Development Partnership with Score Pharma to Advance Biosuperior Antibody Therapeutics Asimov Announces Cell Line Development Partnership with Score Pharma to Advance Biosuperior Antibody Therapeutics March 17, 2026 March 17, 2026 Read more Read more Blog announcement science technology Asimov and AGC Biologics Team Up to Provide a Cost-Effective, Simplified, and Secure Manufacturing Approach for Viral Vector Production Asimov and AGC Biologics Team Up to Provide a Cost-Effective, Simplified, and Secure Manufacturing Approach for Viral Vector Production Asimov and AGC Biologics Team Up to Provide a Cost-Effective, Simplified, and Secure Manufacturing Approach for Viral Vector Production January 12, 2026 January 12, 2026 Read more Read more Blog announcement science technology Asimov Launches CHO Edge Rapid Pools to Bridge Biologics Discovery and CMC with Predictive Stable Expression Asimov Launches CHO Edge Rapid Pools to Bridge Biologics Discovery and CMC with Predictive Stable Expression Asimov Launches CHO Edge Rapid Pools to Bridge Biologics Discovery and CMC with Predictive Stable Expression December 16, 2025 December 16, 2025 Read more Read more Blog announcement science technology Optimizing Bispecific Antibody Expression with Amgen Optimizing Bispecific Antibody Expression with Amgen Optimizing Bispecific Antibody Expression with Amgen December 15, 2025 December 15, 2025 Read more Read more Blog announcement science technology Asimov Launches Stable AAV Producer Cell Lines, Setting a New Standard for Viral Vector Manufacturing Asimov Launches Stable AAV Producer Cell Lines, Setting a New Standard for Viral Vector Manufacturing Asimov Launches Stable AAV Producer Cell Lines, Setting a New Standard for Viral Vector Manufacturing October 6, 2025 October 6, 2025 Read more Read more Blog announcement science technology Asimov Announces Cell Line Development Partnership with Ottimo Pharma to Accelerate Cancer Immunotherapys Path to Clinic Asimov Announces Cell Line Development Partnership with Ottimo Pharma to Accelerate Cancer Immunotherapys Path to Clinic Asimov Announces Cell Line Development Partnership with Ottimo Pharma to Accelerate Cancer Immunotherapys Path to Clinic August 27, 2025 August 27, 2025 Read more Read more Blog announcement science technology Asimov Enters into Agreement with BARDAs BioMaP Consortium to Advance Production of Medical Countermeasures Against Ebola and Deadly Viruses Asimov Enters into Agreement with BARDAs BioMaP Consortium to Advance Production of Medical Countermeasures Against Ebola and Deadly Viruses Asimov Enters into Agreement with BARDAs BioMaP Consortium to Advance Production of Medical Countermeasures Against Ebola and Deadly Viruses August 12, 2025 August 12, 2025 Read more Read more Blog announcement science technology Asimov Announces IND Approval and Clinical Dosing of Bispecific Antibody Produced Using CHO Edge Expression System Asimov Announces IND Approval and Clinical Dosing of Bispecific Antibody Produced Using CHO Edge Expression System Asimov Announces IND Approval and Clinical Dosing of Bispecific Antibody Produced Using CHO Edge Expression System July 9, 2025 July 9, 2025 Read more Read more Blog announcement science technology Cytiva and Asimov collaborate on next generation cell line design and process development Cytiva and Asimov collaborate on next generation cell line design and process development Cytiva and Asimov collaborate on next generation cell line design and process development April 29, 2025 April 29, 2025 Read more Read more Blog announcement science technology LOTTE BIOLOGICS and Asimov Announce Partnership for Accelerated Cell Line Development And Scaling to GMP Manufacturing LOTTE BIOLOGICS and Asimov Announce Partnership for Accelerated Cell Line Development And Scaling to GMP Manufacturing LOTTE BIOLOGICS and Asimov Announce Partnership for Accelerated Cell Line Development And Scaling to GMP Manufacturing March 13, 2025 March 13, 2025 Read more Read more Blog announcement science technology Novo Nordisk license CHO Edge System Novo Nordisk license CHO Edge System Novo Nordisk license CHO Edge System January 13, 2025 January 13, 2025 Read more Read more Blog announcement science technology Asimov and RevOpsis Therapeutics Sign Licensing Agreement for High Titer Multispecific-Expressing Cell Line Asimov and RevOpsis Therapeutics Sign Licensing Agreement for High Titer Multispecific-Expressing Cell Line Asimov and RevOpsis Therapeutics Sign Licensing Agreement for High Titer Multispecific-Expressing Cell Line November 19, 2024 November 19, 2024 Read more Read more Blog announcement science technology Asimov launches AAV Edge, a suite of AI models, host cells, and genetic tools for end-to-end gene therapy development Asimov launches AAV Edge, a suite of AI models, host cells, and genetic tools for end-to-end gene therapy development Asimov launches AAV Edge, a suite of AI models, host cells, and genetic tools for end-to-end gene therapy development September 18, 2024 September 18, 2024 Read more Read more Blog announcement science technology Asimov introduces its AI-driven 4th generation CHO Edge System with increased titer guarantee Asimov introduces its AI-driven 4th generation CHO Edge System with increased titer guarantee Asimov introduces its AI-driven 4th generation CHO Edge System with increased titer guarantee July 30, 2024 July 30, 2024 Read more Read more Blog announcement science technology Asimov achieves 10x improvement in lentiviral production, launches new stable cell line development service Asimov achieves 10x improvement in lentiviral production, launches new stable cell line development service Asimov achieves 10x improvement in lentiviral production, launches new stable cell line development service April 29, 2024 April 29, 2024 Read more Read more Blog announcement science technology Asimov launches LV Edge Packaging System to optimize lentivirus production Asimov launches LV Edge Packaging System to optimize lentivirus production Asimov launches LV Edge Packaging System to optimize lentivirus production January 29, 2024 January 29, 2024 Read more Read more Blog announcement science technology Announcing Asimov Press Announcing Asimov Press Announcing Asimov Press September 5, 2023 September 5, 2023 Read more Read more Blog announcement science technology Asimov Labs Asimov Labs Asimov Labs August 2, 2023 August 2, 2023 Read more Read more Blog announcement science technology Lift Off Lift Off Lift Off May 23, 2023 May 23, 2023 Read more Read more Blog announcement science technology Asimov to Present Data on AI-Designed Tissue Specific Promoters at Upcoming Annual Meeting of the American Society of Gene Cell Therapy ASGCT Asimov to Present Data on AI-Designed Tissue Specific Promoters at Upcoming Annual Meeting of the American Society of Gene Cell Therapy ASGCT Asimov to Present Data on AI-Designed Tissue Specific Promoters at Upcoming Annual Meeting of the American Society of Gene Cell Therapy ASGCT May 11, 2023 May 11, 2023 Read more Read more Blog announcement science technology Asimov Partners With iGEM to Support the Next Generation of Synthetic Biologists Asimov Partners With iGEM to Support the Next Generation of Synthetic Biologists Asimov Partners With iGEM to Support the Next Generation of Synthetic Biologists February 8, 2023 February 8, 2023 Read more Read more Blog announcement science technology Asimov and Center for Breakthrough Medicines Form Strategic Partnership for Viral Vector Production Asimov and Center for Breakthrough Medicines Form Strategic Partnership for Viral Vector Production Asimov and Center for Breakthrough Medicines Form Strategic Partnership for Viral Vector Production January 18, 2023 January 18, 2023 Read more Read more Blog announcement science technology Asimov Raises 200 Million to Advance Therapeutics Design and Manufacturing with Synthetic Biology Asimov Raises 200 Million to Advance Therapeutics Design and Manufacturing with Synthetic Biology Asimov Raises 200 Million to Advance Therapeutics Design and Manufacturing with Synthetic Biology January 5, 2023 January 5, 2023 Read more Read more Blog announcement science technology Forbes Drug Manufacture Has One Huge Flaw.January 5, 2023 January 5, 2023 Read more Read more Blog announcement science technology Asimov Selected by DARPA to Develop Artificial Intelligence Design Engine for Synthetic Biology Asimov Selected by DARPA to Develop Artificial Intelligence Design Engine for Synthetic Biology Asimov Selected by DARPA to Develop Artificial Intelligence Design Engine for Synthetic Biology March 27, 2019 March 27, 2019 Read more Read more Blog announcement science technology STEX25 MIT Startup Exchange Names Asimov to STEX25 MIT Startup Exchange Names Asimov to STEX25 March 19, 2019 March 19, 2019 Read more Read more Blog announcement science technology MitAlumni MIT Spinout Asimov Implements Programming Language for Cells MIT Spinout Asimov Implements Programming Language for Cells February 11, 2019 February 11, 2019 Read more Read more Blog announcement science technology Discovery Magazine How Programmable DNA Strands Could Control Healing How Programmable DNA Strands Could Control Healing January 2, 2019 January 2, 2019 Read more Read more Blog announcement science technology Nature.com The automatic-design tools that are changing synthetic biology The automatic-design tools that are changing synthetic biology December 10, 2018 December 10, 2018 Read more Read more Blog announcement science technology MIT Technology Review Biologists would love to program cells as if they were computer chips Biologists would love to program cells as if they were computer chips February 13, 2018 February 13, 2018 Read more Read more Blog announcement science technology The Business Journals How Cambridge Startup Asimov Is Doing Business With Genetic Circuits How Cambridge Startup Asimov Is Doing Business With Genetic Circuits January 15, 2018 January 15, 2018 Read more Read more Blog announcement science technology TechCrunch Bio-programming toolkit maker Asimov launches with 4.7M from Andreessen Horowitz Bio-programming toolkit maker Asimov launches with 4.7M from Andreessen Horowitz December 19, 2017 December 19, 2017 Read more Read more Blog announcement science technology Xconomy Andreessen Horowitz Backs Asimovs Synthetic Biology CAD Software Andreessen Horowitz Backs Asimovs Synthetic Biology CAD Software December 19, 2017 December 19, 2017 Read more Read more Blog announcement science technology The Business Journals Andreessen Horowitz leads seed round in MIT-born genetic circuits startup Andreessen Horowitz leads seed round in MIT-born genetic circuits startup December 19, 2017 December 19, 2017 Read more Read more Blog announcement science technology Medium Genetic Circuits Startup Asimov Raises Seed Round Led by Andreessen Horowitz Genetic Circuits Startup Asimov Raises Seed Round Led by Andreessen Horowitz December 18, 2017 December 18, 2017 Read more Read more Blog announcement science technology Andreessen Horowitz Asimov Asimov January 1, 2017 January 1, 2017 Read more Read more Blog announcement science technology Scientific American Cellular Circuit Computes with DNA Cellular Circuit Computes with DNA April 1, 2016 April 1, 2016 Read more Read more Blog announcement science technology Massachusetts Institute of Technology A programming language for living cells A programming language for living cells March 31, 2016 March 31, 2016 Read more Read more CONTACT US Were hiring at the intersection of biology, engineering, and machine learning.

Title

Asimov — Intelligent Design

Description

Asimov builds tools to program living cells. We're integrating mammalian synthetic biology with computer-aided design to advance therapeutic applications.

Downstreams

substack.com, ashbyhq.com, twitter.com, linkedin.com, forbes.com, mit.edu, discovermagazine.com, nature.com, technologyreview.com, techcrunch.com, a16z.com, scientificamerican.com, lever.co

NS Lookup

A 198.202.211.1

Dates

Created 2026-10-19

Updated 2026-10-19

Summarized 2026-10-19